Amino acid replacement: D2V.
Nucleotide substitution: A89T.
A12447741T
A89T
D2V | vrs-PA
D2V
vrsZ2566 does not complement Df(3)Desat11573-C'1, Df(3R)ED5610 or Df(3R)Exel7316.
Early embryos (mitotic cycles 1-3) derived from vrsZ2566 homozygous fathers and control mothers show asynchrony in nuclear cycles and an array of chromosome defects, including chromosome loss, micronuclei at interphase, isolated chromosomes at metaphase, lagging chromosomes and bridges at anaphase and telophase, as compared to controls. A significant proportion of embryos derived from vrsZ2566/Df(3)Desat11573-C'1 transheterozygous fathers and control mothers also show loss of chromosomes, as compared to heterozygous fathers.
Homozygous males are fertile, but their progeny show paternal chromosome loss (loss rate of chromosome 4 is 8%). The timing of the chromosome loss has not been determined but there is no cytological evidence for chromosome loss during spermatogenesis.
Two paternal copies of vrsEGFP rescue the loss of chromosomes observed in the embryos derived from vrsZ2566/Df(3)Desat11573-C'1 transheterozygous fathers and control mothers.